|
Report Date : |
17.10.2013 |
IDENTIFICATION DETAILS
|
Name : |
RANBAXY ( |
|
|
|
|
Registered Office : |
Lot 6.05, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Date of Incorporation : |
26.08.1982 |
|
|
|
|
Com. Reg. No.: |
89186-K |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacturer and distributor
of pharmaceutical products for oral use comprising liquid formulations,
tablets, capsules and granules for suspension. |
|
|
|
|
No. of Employees : |
200 [2013] |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
Malaysia |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
MAlaysia ECONOMIC OVERVIEW
Malaysia, a
middle-income country, has transformed itself since the 1970s from a producer of
raw materials into an emerging multi-sector economy. Under current Prime
Minister NAJIB, Malaysia is attempting to achieve high-income status by 2020
and to move farther up the value-added production chain by attracting
investments in Islamic finance, high technology industries, biotechnology, and
services. NAJIB's Economic Transformation Program (ETP) is a series of projects
and policy measures intended to accelerate the country's economic growth. The
government has also taken steps to liberalize some services sub-sectors. The
NAJIB administration also is continuing efforts to boost domestic demand and
reduce the economy''s dependence on exports. Nevertheless, exports -
particularly of electronics, oil and gas, palm oil and rubber - remain a
significant driver of the economy. As an oil and gas exporter, Malaysia has
profited from higher world energy prices, although the rising cost of domestic
gasoline and diesel fuel, combined with strained government finances, has
forced Kuala Lumpur to begin to reduce government subsidies. The government is
also trying to lessen its dependence on state oil producer Petronas. The oil
and gas sector supplies about 35% of government revenue in 2011. Bank Negera
Malaysia (central bank) maintains healthy foreign exchange reserves, and a
well-developed regulatory regime has limited Malaysia''s exposure to riskier
financial instruments and the global financial crisis. Nevertheless, Malaysia
could be vulnerable to a fall in commodity prices or a general slowdown in
global economic activity because exports are a major component of GDP. In order
to attract increased investment, NAJIB has raised possible revisions to the
special economic and social preferences accorded to ethnic Malays under the New
Economic Policy of 1970, but he has encountered significant opposition,
especially from Malay nationalists and other vested interests.
Source : CIA
|
*
Adopted abbreviations : |
SC - Subject Company (the company enquired
by you) |
|
|
|
|
|
N/A - Not Applicable |
|
|
REGISTRATION NO. |
: |
89186-K |
||||
|
COMPANY NAME |
: |
RANBAXY
(MALAYSIA) SDN. BHD. |
||||
|
FORMER NAME |
: |
N/A |
||||
|
INCORPORATION DATE |
: |
26/08/1982 |
||||
|
|
|
|
||||
|
|
|
|
||||
|
COMPANY STATUS |
: |
EXIST |
||||
|
LEGAL FORM |
: |
PRIVATE LIMITED |
||||
|
LISTED STATUS |
: |
NO |
||||
|
|
|
|
||||
|
|
|
|
||||
|
REGISTERED ADDRESS |
: |
LOT 6.05, KPMG TOWER, 8 FIRST AVENUE,
BANDAR UTAMA, LEVEL 6, 47800 PETALING JAYA, SELANGOR, MALAYSIA. |
||||
|
BUSINESS ADDRESS |
: |
WISMA SELANGOR DREDGING SOUTH BLOCK, 5TH FLOOR,
142A, JALAN AMPANG, 50450 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA. |
||||
|
TEL.NO. |
: |
03-21614181 |
||||
|
FAX.NO. |
: |
03-21627593 |
||||
|
WEB SITE |
: |
|||||
|
CONTACT PERSON |
: |
JEYABALAN THANGARAJAH ( MANAGING DIRECTOR
) |
||||
|
|
|
|
||||
|
INDUSTRY CODE |
: |
21001 |
||||
|
PRINCIPAL ACTIVITY |
: |
MANUFACTURE AND DISTRIBUTION OF
PHARMACEUTICAL PRODUCTS |
||||
|
AUTHORISED CAPITAL |
: |
MYR 12,000,000.00 DIVIDED INTO |
||||
|
ISSUED AND PAID UP CAPITAL |
: |
MYR 8,000,000.00 DIVIDED INTO |
||||
|
|
|
|
||||
|
SALES |
: |
MYR 86,726,000 [2011] |
||||
|
NET WORTH |
: |
MYR 74,781,000 [2011] |
||||
|
|
|
|
||||
|
STAFF STRENGTH |
: |
200 [2013] |
||||
|
||||||
|
LITIGATION |
: |
CLEAR |
||||
|
DEFAULTER CHECK |
: |
CLEAR |
||||
|
FINANCIAL CONDITION |
: |
STRONG |
||||
|
PAYMENT |
: |
GOOD |
||||
|
MANAGEMENT CAPABILITY |
: |
AVERAGE |
||||
|
|
|
|
||||
|
COMMERCIAL RISK |
: |
LOW |
||||
|
CURRENCY EXPOSURE |
: |
MODERATE |
||||
|
GENERAL REPUTATION |
: |
GOOD |
||||
|
INDUSTRY OUTLOOK |
: |
AVERAGE GROWTH |
||||
The SC is a private limited company and is allowed to have a minimum of one and a maximum of forty-nine shareholders. As a private limited company, the SC must have at least two directors. A private limited company is a separate legal entity from its shareholders. As a separate legal entity, the SC is capable of owning assets, entering into contracts, sue or be sued by other companies. The liabilities of the shareholders are to the extent of the equity they have taken up and the creditors cannot claim on shareholders' personal assets even if the SC is insolvent. The SC is governed by the Companies Act, 1965 and the company must file its annual returns, together with its financial statements with the Registrar of Companies.
The SC is principally engaged in the (as a / as an) manufacture and distribution of pharmaceutical products.
The SC is not listed on Bursa Malaysia (Malaysia Stock Exchange).
The major
shareholder(s) of the SC are shown as follows :
Name |
Address |
IC/PP/Loc No |
Shareholding |
(%) |
|
RANBAXY LABORATORIES LTD |
A-41, INDUSTRIAL AREA PHASE VIII-A, SAHIBZADA AJIT SINGH NAGAR, MOHALI, 160071 PUNJAB, INDIA. |
INAF3747 |
3,189,248.00 |
39.87 |
|
RANBAXY (NETHERLANDS) BV |
PRINS BERNHARDPLEIN 200, 1097JB AMSTERDAM, NETHERLANDS. |
NL011028 |
2,507,617.00 |
31.35 |
|
STATUS RESOURCES SDN BHD |
MENARA TUN RAZAK, JALAN RAJA LAUT, TINGKAT 31, 50350 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA. |
148518P |
666,985.00 |
8.34 |
|
MS. APARAJITHA A/P M.P.KRISHNAN |
3, JALAN SUNGAI CHUA, 43000 KAJANG, SELANGOR, MALAYSIA. |
740125-14-5734 A2581876 |
186,000.00 |
2.33 |
|
MS. CHEAH SOO SEE |
51, JALAN CHAN CHIN MOOI, TAMAN TITIWANGSA, OFF JALAN PAHANG, 53200 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA. |
540120-07-5080 4565454 |
150,170.00 |
1.88 |
|
AINLI SDN BHD |
LOT 6.05, KPMG TOWER, 8 FIRST AVENUE, BANDAR UTAMA, LEVEL 6, 47800 PETALING JAYA, SELANGOR, MALAYSIA. |
47079W |
139,763.00 |
1.75 |
|
DR S S GILL |
48, JALAN TANJONG, 46000 PETALING JAYA, SELANGOR, MALAYSIA. |
330313-10-5201 1863516 |
132,651.00 |
1.66 |
|
KINOSHITA CORPORATION SDN BHD |
5, JALAN KOLEJ MELAYU, 33000 KUALA KANGSAR, PERAK, MALAYSIA. |
59013D |
120,136.00 |
1.50 |
|
DR MOHAMAD HARUN |
KLINIK MOHD HARUN, 1962, JALAN DATO' PATI, 15000 KOTA BHARU, KELANTAN, MALAYSIA. |
480824-03-5413 0817831 |
100,000.00 |
1.25 |
|
DATO' DR MOHD ZAINEE BIN HAJI GHAZALI |
POLIKLINIK HIDAYAH, 4B, ARKED MARA, 71300 REMBAU, NEGERI SEMBILAN, MALAYSIA. |
520218-08-6003 4257940 |
82,872.00 |
1.04 |
|
MS. RASANAYAKI A/P KRISHNARAJA |
5735-C, KLEBANG BESAR, 75200 MELAKA, MELAKA, MALAYSIA. |
490328-10-5338 1154249 |
69,679.00 |
0.87 |
|
DR MOHD ISHAK SYED AHMAD |
6, JALAN TENGKERA, 75200 MELAKA, MELAKA, MALAYSIA. |
460103-10-5567 7074148 |
57,115.00 |
0.71 |
|
MS. SHAMSUNNISA BTE MA ABDUL JABBAR @ SHAMSUN NAHAR BTE MA ABDUL JABBAR |
6, JALAN TENGKERA, 75200 MELAKA, MELAKA, MALAYSIA. |
580409-71-5284 5310329 |
57,115.00 |
0.71 |
|
MS. JAMILAH AKHTAR BINTI ABDUL RAHMAN |
1916-E, TAMAN STADIUM, JALAN STADIUM, 05100 ALOR SETAR, KEDAH, MALAYSIA. |
540613-02-5806 |
50,000.00 |
0.63 |
|
DR NIRMALA MENON |
11, LORONG SENYUM MATAHARI, COUNTRY HEIGHTS, 43000 KAJANG, SELANGOR, MALAYSIA. |
591123-71-5282 5825081 |
48,054.00 |
0.60 |
|
DATO' DR SAMBANTHAN UNDERWOOD |
5, JALAN KOLEJ MELAYU, 33000 KUALA KANGSAR, PERAK, MALAYSIA. |
290210-71-5265 3092898 |
48,054.00 |
0.60 |
|
DR PETER RAVINDRAN RICHARDS A/L JAMES RICHARDS |
3, DESA ROS, 43000 KAJANG, SELANGOR, MALAYSIA. |
521018-10-5833 |
36,041.00 |
0.45 |
|
MS. NATASHA MENON |
11, LORONG SENYUM MATAHARI, COUNTRY HEIGHTS, 43000 KAJANG, SELANGOR, MALAYSIA. |
850705-14-6044 |
35,000.00 |
0.44 |
|
DR HAMID ARSHAT |
75M, MEDAN SETIA SATU, PLAZA DAMANSARA, BUKIT DAMANSARA, 50490 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA. |
450104-01-5177 2776605 |
31,250.00 |
0.39 |
|
DR A S DASS |
KLINIK REDDY KAJANG, 182, JALAN LANGAT 2, TAMAN SRI LANGAT, JALAN REKO, 43000 KAJANG, SELANGOR, MALAYSIA. |
460612-07-5335 2659081 |
30,000.00 |
0.38 |
|
INNIRA D/O M G NAIR @ INDRA D/O M G NAIR |
5, JALAN KENT SATU, OFF JALAN MAKTAB, 54000 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA. |
0591799 |
24,988.00 |
0.31 |
|
DR JEYA VATHANA A/P M. SELVARATNAM |
18/279, JALAN HUTAN REKREASI, OFF JALAN TUAN HJ SAID, 70100 SEREMBAN, NEGERI SEMBILAN, MALAYSIA. |
531118-05-5000 8162510 |
24,027.00 |
0.30 |
|
DATIN VIJAYA LAKSHMI PONNIAH |
44, JALAN LABU LAMA (AST), 70200 SEREMBAN, NEGERI SEMBILAN, MALAYSIA. |
430602-07-5262 1339345 |
20,000.00 |
0.25 |
|
MR. SURAJ ASHROFF SHARON BIN MOHAMAD ALI |
KLINIK ALI, 34, JALAN GENUANG KAMPUNG, 85000 SEGAMAT, JOHOR, MALAYSIA. |
730804-03-5263 A2502798 |
20,000.00 |
0.25 |
|
EKIM HOLDINGS SDN BHD |
10, JALAN SS1/24, KAMPUNG TUNKU, 47300
PETALING JAYA, SELANGOR, MALAYSIA. |
76415M |
16,400.00 |
0.21 |
|
DR MOIZ BIN SIRAJ |
KLINIK MOIZ, 32, JALAN NIAGA SATU, 81900
KOTA TINGGI, JOHOR, MALAYSIA. |
511126-01-5641
4169530 |
13,439.00 |
0.17 |
|
DR N K S THARMASEELAN A/L N K SINNADORAI |
WISMA N.K.S., LOT 855/1, BATU 1/2, JALAN
PANTAI, 71000 PORT DICKSON, NEGERI SEMBILAN, MALAYSIA. |
490906-10-5437
2909279 |
12,014.00 |
0.15 |
|
DR VETHALINGAM A/L PALANIANDY PILLAY @ VYTHILINGAM
A/L PALANIANDY PILLAY |
KELINIK RAJ & RAKAN-RAKAN, 778, JALAN
SENTUL, 51000 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA. |
480508-08-5945 |
10,812.00 |
0.14 |
|
PREETHA FERNANDES A/P C.A.J. FERNANDES
& PRANESH A. DOMINIC (ADMINISTRATOR OF DR. ROBERT DOMINIC) |
1, LORONG 4/48F, 46050 PETALING JAYA,
SELANGOR, MALAYSIA. |
|
10,000.00 |
0.13 |
|
DR ABDULLAH BIN ABDUL RAHMAN |
10, LORONG KENARI 4, TAMAN PAROI JAYA,
70400 SEREMBAN, NEGERI SEMBILAN, MALAYSIA. |
451013-08-5537
2000735 |
10,000.00 |
0.13 |
|
DR SHEK DAUD BIN HAMID |
42, LEBUH SUNGAI PINANG 1, TINGKAT BAWAH,
11600 PULAU PINANG, PULAU PINANG, MALAYSIA. |
540827-07-5279
4672516 |
10,000.00 |
0.13 |
|
DR M. RAVINDRAN |
KELINIK PANTAI, 532/29, TAMAN MEWAH, 1 1/4
MILE JALAN PANTAI, 71000 PORT DICKSON, NEGERI SEMBILAN, MALAYSIA. |
450110-08-5649
1039297 |
10,000.00 |
0.13 |
|
DR SELVAKUMAR A/L MURUGIAH |
LOT 357, BUKIT AMPANG INDAH, 44000 KUALA
KUBU BARU, SELANGOR, MALAYSIA. |
521205-08-6199
4380974 |
10,000.00 |
0.13 |
|
DR NAWAWI BIN TAMBY |
MESRA GROUP CLINICS, 28-29, HOLIDAY PLAZA
TOWER, JALAN DATO' SULAIMAN, CENTURY GARDEN, F FLOOR, 80250 JOHOR BAHRU,
JOHOR, MALAYSIA. |
451018-04-5091
0857449 |
10,000.00 |
0.13 |
|
MR. MUHAMAD MAIDEN BIN M.K.M. ABD MAJID |
5, JALAN BJ/6A, TAMAN BUKIT JAYA, BUKIT
ANTARABANGSA, 68000 AMPANG, SELANGOR, MALAYSIA. |
530715-08-5801
4516091 |
9,000.00 |
0.11 |
|
DR THURAIRAJU S/O S KRISHNA |
KELINIK RAJ & RAKAN-RAKAN, 778, JALAN SENTUL,
51000 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA. |
460807-08-5541
7962856 |
9,000.00 |
0.11 |
|
DR VELAYUDHAM A/L LAKSHMANAN |
121, JALAN IPOH, 51200 KUALA LUMPUR,
WILAYAH PERSEKUTUAN, MALAYSIA. |
380310-71-5077
7991204 |
8,410.00 |
0.11 |
|
ANGELINA SAROJA |
7, JALAN 16/144A, TAMAN BUKIT CHERAS,
56000 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA. |
471007-10-5720
2988615 |
8,410.00 |
0.11 |
|
DATIN VIJAYALETCHUMY A/P RAMASAMY |
76, TAMAN ZAABA, TAMAN TUN DR ISMAIL 1, 60000
KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA. |
471010-05-5226
7695177 |
7,208.00 |
0.09 |
|
DR MOHD SULAIMAN HAMAT |
KELINIK MOHD SULAIMAN, 59D, JALAN TOK LAM,
20100 KUALA TERENGGANU, TERENGGANU, MALAYSIA. |
540503-03-5107
4601548 |
5,996.00 |
0.07 |
|
JOSEPH ARUL |
90-H, JALAN PERGAM, 08000 SUNGAI PETANI,
KEDAH, MALAYSIA. |
460304-08-5101
7746542 |
5,000.00 |
0.06 |
|
DR MOHD SALLEHIN BIN HJ ABU BAKAR |
POLIKLINIK PENAWAR, 15, TAMAN SRI
KAMUNTING, JALAN STESYEN, 84000 MUAR, JOHOR, MALAYSIA. |
560429-05-5289
4948765 |
5,000.00 |
0.06 |
|
MS. SANTHA BHASKARA MENON + |
BLOCK E, APARTMENT 6, SUNWAY VIVALDI MONT
KIARA, 1, JALAN 19/70A, DESA SRI HARTAMAS, 7TH FLOOR-, 50480 KUALA LUMPUR,
WILAYAH PERSEKUTUAN, MALAYSIA. |
371219-71-5258
7788459 |
1,046.00 |
0.01 |
|
DR PARAMESWARAN KRISHNAN |
KAJANG KELINIK, 3, JALAN SUNGEI CHUA,
43000 KAJANG, SELANGOR, MALAYSIA. |
4116356 |
1,500.00 |
0.02 |
|
|
|
|
--------------- |
------ |
|
|
|
|
8,000,000.00 |
100.00 |
|
|
|
|
============ |
===== |
+ Also Director
DIRECTOR 1
|
Name Of Subject |
: |
DATO' ABDULLAH BIN MOHD YUSOF |
|
Address |
: |
28, JALAN SETIAMURNI 12, BUKIT DAMANSARA,
50490 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA. |
|
IC / PP No |
: |
4071934 |
|
New IC No |
: |
390505-01-5627 |
|
Date of Birth |
: |
05/05/1939 |
|
|
|
|
|
Nationality |
: |
MALAYSIAN |
|
Date of Appointment |
: |
09/12/1987 |
|
|
|
|
|
Qualification |
: |
HE GRADUATED FROM THE UNIVERSITY OF SINGAPORE
WITH A BACHELOR OF LAWS (HONOURS) DEGREE IN 1968. |
|
Profile |
: |
HE IS AN ADVOCATE AND SOLICITOR, HAVING
HIS OWN LEGAL PRACTISE SINCE 1970. |
|
|
|
|
DIRECTOR 2
|
Name Of Subject |
: |
MR. JEYABALAN A/L V. THANGARAJAH |
|
Address |
: |
727, HAPPY GARDEN, JALAN RIANG 3, 58200
KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA. |
|
IC / PP No |
: |
5955553 |
|
New IC No |
: |
600522-10-6881 |
|
Date of Birth |
: |
22/05/1960 |
|
|
|
|
|
Nationality |
: |
MALAYSIAN |
|
Date of Appointment |
: |
04/11/1997 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DIRECTOR 3
|
Name Of Subject |
: |
ASHWANI KUMAR MALHOTRA |
|
Address |
: |
FLAT 8 MEGHNA AMBUJA, 191, ROAD 7, WEST
MARREDPALLY SECUNDERABAD, 500026 ANDHRA PRADESH |
|
IC / PP No |
: |
G3636497 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Nationality |
: |
INDIAN |
|
Date of Appointment |
: |
04/02/2011 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DIRECTOR 4
|
Name Of Subject |
: |
RAJEEV SHARMA |
|
Address |
: |
A-2-5, MONT KIARA AMAN, JALAN KIARA 2,
MONT KIARA, 50480 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA. |
|
IC / PP No |
: |
Z2109620 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Nationality |
: |
INDIAN |
|
Date of Appointment |
: |
03/05/2011 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DIRECTOR 5
|
Name Of Subject |
: |
RAJIV GULATI |
|
Address |
: |
B-3, 1701, UNITECH WORLD SPA, SECTOR-30,
GURGAON, INDIA |
|
IC / PP No |
: |
Z2161770 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Nationality |
: |
INDIAN |
|
Date of Appointment |
: |
18/05/2012 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DIRECTOR 6
|
Name Of Subject |
: |
INDRAJIT BANERJEE |
|
Address |
: |
F-100, EAST OF KAILASH, NEW DELHI 110 065
INDIA, 2ND FLOOR |
|
IC / PP No |
: |
Z2067464 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Nationality |
: |
INDIAN |
|
Date of Appointment |
: |
18/05/2012 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DIRECTOR 7
|
Name Of Subject |
: |
MS. SANTHA BHASKARA MENON |
|
Address |
: |
BLOCK E, APARTMENT 6, SUNWAY VIVALDI MONT
KIARA, 1, JALAN 19/70A, DESA SRI HARTAMAS, 7TH FLOOR-, 50480 KUALA LUMPUR,
WILAYAH PERSEKUTUAN, MALAYSIA. |
|
IC / PP No |
: |
7788459 |
|
New IC No |
: |
371219-71-5258 |
|
Date of Birth |
: |
19/12/1937 |
|
|
|
|
|
Nationality |
: |
MALAYSIAN |
|
Date of Appointment |
: |
26/08/1982 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1) |
Name of Subject |
: |
ASHWANI KUMAR MALHOTRA |
|
|
Position |
: |
EXECUTIVE VICE PRESIDENT |
|
|
|
|
|
|
2) |
Name of Subject |
: |
INDRAJIT BANERJEE |
|
|
Position |
: |
CHIEF FINANCE OFFICER |
|
|
|
|
|
|
3) |
Name of Subject |
: |
JEYABALAN THANGARAJAH |
|
|
Position |
: |
MANAGING DIRECTOR |
|
|
|
|
|
|
4) |
Name of Subject |
: |
KAMALNATHHAN |
|
|
Position |
: |
BUSINESS DEVELOPMENT MANAGER |
|
Auditor |
: |
KPMG |
|
Auditor' Address |
: |
KPMG TOWER, 8 FIRST AVENUE, BANDAR UTAMA,
LEVEL 10, 47800 PETALING JAYA, SELANGOR, MALAYSIA. |
|
|
|
|
|
1) |
Company Secretary |
: |
MS. AMBIKAI A/P BALA SINGHAM |
|
|
IC / PP No |
: |
A1008414 |
|
|
New IC No |
: |
680722-10-5894 |
|
|
Address |
: |
28, JALAN PUYOH, BATU 3, JALAN IPOH, 51100
KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA. |
Banking relations are maintained principally with :
|
1) |
Name |
: |
DEUTSCHE BANK (MALAYSIA) BHD |
|
|
|
|
|
|
Charge No |
Creation Date |
Charge
Description |
Chargee Name |
Total Charge |
Status |
|
1 |
17/09/1984 |
N/A |
UNITED ASIAN BANK BHD |
MYR 100,000.00 |
Unsatisfied |
|
1 (BK 272/98) |
17/09/1984 |
DEPOSIT |
UNITED ASIAN BANK BHD |
MYR 100,000.00 |
Unsatisfied |
|
2 |
17/09/1984 |
N/A |
UNITED ASIAN BANK BHD |
MYR 65,000.00 |
Unsatisfied |
|
2 (BK 272/98) |
17/09/1984 |
DEPOSIT |
UNITED ASIAN BANK BHD |
MYR 65,000.00 |
Unsatisfied |
|
3 |
08/01/1986 |
N/A |
HONGKONG BANK MALAYSIA BERHAD |
N/A |
Satisfied |
|
4 |
09/03/1987 |
N/A |
HONGKONG BANK MALAYSIA BERHAD |
N/A |
Satisfied |
|
5 |
11/11/1987 |
N/A |
HONGKONG BANK MALAYSIA BERHAD |
N/A |
Satisfied |
|
6 |
17/02/2003 |
N/A |
HSBC BANK MALAYSIA BERHAD |
N/A |
Satisfied |
|
7 |
28/01/2010 |
A CHARGE ON
DEPOSITT |
DEUTSCHE BANK (MALAYSIA) BHD |
N/A |
Satisfied |
* A check has been conducted in our databank against the SC whether the subject
has been involved in any litigation. Our databank consists of 99% of the wound
up companies in Malaysia.
No legal action was found in our databank.
No winding up petition was found in our databank.
* We have checked through the SC in our defaulters' database which comprised of
debtors that have been blacklisted by our customers and debtors that have been
placed or assigned to us for collection since 1990. Information was provided by
third party where the debt amount can be disputed. Please check with creditors
for confirmation as alleged debts may have been paid since recorded or are
being disputed.
No blacklisted record & debt collection case was found in our defaulters'
databank.
|
SOURCES OF RAW MATERIALS: |
|
||||
|
Local |
: |
YES |
Percentage |
: |
45% |
|
Overseas |
: |
YES |
Percentage |
: |
55% |
|
Import Countries |
: |
INDIA |
|||
The SC refused to provide any name of trade/service supplier and we are unable
to conduct any trade enquiry. However, from financial historical data we
conclude that :
|
OVERALL PAYMENT HABIT |
||||||||||||||
|
Prompt 0-30 Days |
[ |
|
] |
|
Good 31-60 Days |
[ |
X |
] |
|
Average 61-90 Days |
[ |
|
] |
|
|
Fair 91-120 Days |
[ |
|
] |
|
Poor >120 Days |
[ |
|
] |
|
|
|
|
|
|
|
Local |
: |
YES |
Percentage |
: |
60% |
|
Domestic Markets |
: |
MALAYSIA |
|||
|
Overseas |
: |
YES |
Percentage |
: |
40% |
|
Export Market |
: |
ASIA |
|||
|
Credit Term |
: |
30 - 60 DAYS |
|||
|
|
|
|
|
|
|
|
Payment Mode |
: |
CHEQUES |
|||
|
Type of Customer |
: |
PHARMACIES,HOSPITALS,DEALERS |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Products manufactured |
: |
|
|||||
|
|
|
|
|||||
|
Brand Name |
: |
LESTRIC, INVORIL, CASCOR, XL, HISTAC
|
|||||
|
|
|
|
|||||
|
Competitor(s) |
: |
ALPHA BIOLOGICS SDN BHD
|
|||||
|
|
|
|
|||||
|
Ownership of premises |
: |
OWNED
|
|||||
|
Factory
/ Premises |
: |
LOT 23, BAKAR ARANG INDUSTRIAL ESTATE, 08000 SUNGAI
PETANI, KEDAH, MALAYSIA.
|
|
Total Number of Employees: |
|
||||||||
|
YEAR |
2013 |
2012 |
2011 |
2010 |
2009 |
|
|
|
|
|
|
|||||||||
|
GROUP |
N/A |
N/A |
N/A |
N/A |
N/A |
|
|
|
|
|
COMPANY |
200 |
200 |
200 |
200 |
190 |
|
|
|
|
|
Branch |
: |
NO
|
Other
Information:
The SC is principally engaged in the (as a / as an) manufacture and
distribution of pharmaceutical products.
The SC is a subsidiaries company of Ranbaxy Laboratories Limited (RLL) based in
India.
The SC's products are for oral use comprising liquid formulations, tablets,
capsules and granules for suspension.
According to the SC, it has more than 40 types of medicines.
Besides that, the SC equipped with automated and semi-automated machineries to
ensure production of high quality products .
The SC has foreign workers from India on its production site.
The SC has a major presence in the areas of Cardio vascular, Antibiotic, Pain
Management, Gastrointestinal and Food Supplement, Threpentic segments and
others.
Numerous products of the SC are brand leaders in the hospital and general
practitioners (GP) markets such as Invoril and others.
August 08, 2013
Kuala Lumpur, Malaysia; Gurgaon, India: Ranbaxy Malaysia Sdn Bhd (RMSB) today
announced that it has been allocated the site for setting up its Greenfield
manufacturing facility in Malaysia. The company signed a ‘letter of offer’
agreement with Kulim Hi Tech Park (KHTP), a wholly owned state agency and
industrial park that houses various other leading industries. KHTP is located
at Kulim in the state of Kedah, Malaysia.
The Ranbaxy Greenfield facility will be built on an area of around 15 acres
with an investment of around US$ 35 million providing employment to over 200
people. This will be Ranbaxy’s second manufacturing plant in Malaysia. Last
year in September, the Government of Malaysia gave an approval to RMSB for
setting up a Greenfield manufacturing facility in Malaysia as an Entry Point
Project (EPP).
The RMSB new facility would manufacture dosage forms including tablets and
capsules primarily in the Cardiovascular, Anti Diabetic, Anti-infective and
Gastrointestinal segments. Ranbaxy’s total output in Malaysia will be increased
from 1 Billion doses/annum to 3 Billion doses/annum when the new facility is
fully operational.
Latest fresh
investigations carried out on the SC indicated that :
|
Telephone Number Provided By Client |
: |
0321614181 |
|
Current Telephone Number |
: |
03-21614181 |
|
Match |
: |
YES |
|
|
|
|
|
Address Provided by Client |
: |
Sangai petant Let
23 Bakar Aray Industrial Estate 08000 Gunga Petant Kedah, Malaysia |
|
Current Address |
: |
WISMA SELANGOR DREDGING SOUTH BLOCK, 5TH
FLOOR, 142A, JALAN AMPANG, 50450 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA. |
|
Match |
: |
No |
|
|
|
|
|
Latest Financial Accounts |
: |
YES |
Other
Investigations
we contacted one of the staff from the SC and they provided some information on the SC.
The address provided by client is factory address of the subject.
|
|
|
|
|
|
|
Profitability |
|
|
|
|
|
|
|
Turnover |
: |
Decreased |
[ |
2007 - 2011 |
] |
|
|
Profit/(Loss) Before Tax |
: |
Decreased |
[ |
2007 - 2011 |
] |
|
|
Return on Shareholder Funds |
: |
Unfavourable |
[ |
8.05% |
] |
|
|
Return on Net Assets |
: |
Acceptable |
[ |
10.70% |
] |
|
|
|
|
|
|
|
|
|
|
The continuous fall in turnover could be
due to the lower demand for the SC's products / services.The SC's profit fell
sharply because of the high operating costs incurred. The unfavourable return
on shareholders' funds could indicate that the SC was inefficient in
utilising its assets to generate returns. |
||||||
|
|
|
|
|
|
|
|
|
Working Capital
Control |
|
|
|
|
|
|
|
Stock Ratio |
: |
Unfavourable |
[ |
130 Days |
] |
|
|
Debtor Ratio |
: |
Unfavourable |
[ |
200 Days |
] |
|
|
Creditors Ratio |
: |
Favourable |
[ |
35 Days |
] |
|
|
|
|
|
|
|
|
|
|
The SC could be incurring higher holding
cost. As its capital was tied up in stocks, it could face liquidity problems.
The SC's debtors ratio was high. The SC should tighten its credit control and
improve its collection period. The SC had a favourable creditors' ratio where
the SC could be taking advantage of the cash discounts and also wanting to
maintain goodwill with its creditors. |
||||||
|
|
|
|
|
|
|
|
|
Liquidity |
|
|
|
|
|
|
|
Liquid Ratio |
: |
Favourable |
[ |
1.56 Times |
] |
|
|
Current Ratio |
: |
Favourable |
[ |
2.44 Times |
] |
|
|
|
|
|
|
|
|
|
|
A minimum liquid ratio of 1 should be maintained
by the SC in order to assure its creditors of its ability to meet short term
obligations and the SC was in a good liquidity position. Thus, we believe the
SC is able to meet all its short term obligations as and when they fall due. |
||||||
|
|
|
|
|
|
|
|
|
Solvency |
|
|
|
|
|
|
|
Interest Cover |
: |
Favourable |
[ |
10.59 Times |
] |
|
|
Gearing Ratio |
: |
Favourable |
[ |
0.15 Times |
] |
|
|
|
|
|
|
|
|
|
|
The interest cover showed that the SC was able
to service the interest. The favourable interest cover could indicate that
the SC was making enough profit to pay for the interest accrued. The SC was
lowly geared thus it had a low financial risk. The SC was mainly financed by
its shareholders' funds and internally generated funds. In times of economic
slowdown / downturn, the SC being a lowly geared company, will be able to
compete better than those companies which are highly geared in the same
industry. |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Overall
Assessment : |
|
|
|
|
|
|
|
The SC's performance deteriorated over the
years with lower turnover and profit. The SC was in good liquidity position
with its total current liabilities well covered by its total current assets. With
its current net assets, the SC should be able to repay its short term
obligations. With the favourable interest cover, the SC could be able to
service all the accrued interest without facing any difficulties. The SC as a
lowly geared company, will be more secured compared to those highly geared
companies. It has the ability to meet all its long term obligations. |
||||||
|
|
|
|
|
|
|
|
|
Overall
financial condition of the SC : STRONG |
||||||
|
Major Economic
Indicators: |
2009 |
2010 |
2011 |
2012* |
2013** |
|
|
|
|
|
|
|
|
Population ( Million) |
28.13 |
28.35 |
28.70 |
29.30 |
29.80 |
|
Gross Domestic
Products ( % ) |
<0.5> |
7.2 |
5.1 |
5.6 |
5.3 |
|
Domestic Demand ( % ) |
2.9 |
6.3 |
8.2 |
9.4 |
5.6 |
|
Private
Expenditure ( % ) |
<2.7> |
8.1 |
8.2 |
8.0 |
7.4 |
|
Consumption ( % ) |
0.7 |
6.7 |
7.1 |
1.0 |
5.7 |
|
Investment ( % ) |
<17.2> |
17.7 |
12.2 |
11.7 |
13.3 |
|
Public
Expenditure ( % ) |
5.2 |
3.8 |
8.4 |
13.3 |
1.2 |
|
Consumption ( % ) |
3.1 |
0.2 |
16.1 |
11.3 |
<1.2> |
|
Investment ( % ) |
8.0 |
2.8 |
<0.3> |
15.9 |
4.2 |
|
|
|
|
|
|
|
|
Balance of Trade ( MYR Million ) |
89,650 |
118,356 |
116,058 |
106,300 |
110,700 |
|
Government Finance ( MYR Million ) |
<28,450> |
<40,482> |
<45,511> |
<42,297> |
<39,993> |
|
Government
Finance to GDP / Fiscal Deficit ( % ) |
<4.8> |
<5.6> |
<5.4> |
<4.5> |
<4.0> |
|
Inflation ( % Change in Composite CPI) |
<5.2> |
5.1 |
3.1 |
1.6 |
2.5 |
|
Unemployment Rate |
4.5 |
3.9 |
3.3 |
3.2 |
3.0 |
|
|
|
|
|
|
|
|
Net International Reserves ( MYR Billion ) |
331 |
329 |
415 |
427 |
- |
|
Average Risk-Weighted Capital Adequacy
Ratio ( % ) |
2.87 |
2.20 |
3.50 |
2.20 |
- |
|
Average 3 Months
of Non-performing Loans ( % ) |
11.08 |
15.30 |
14.80 |
14.70 |
- |
|
Average Base Lending Rate ( % ) |
5.53 |
6.30 |
6.60 |
6.53 |
- |
|
Business Loans Disbursed( % ) |
10.5 |
14.7 |
15.3 |
32.2 |
- |
|
Foreign Investment ( MYR Million ) |
22,156.8 |
22,517.9 |
23,546.1 |
26,230.4 |
- |
|
Consumer Loans ( % ) |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
Registration of
New Companies ( No. ) |
41,578 |
44,148 |
45,455 |
45,441 |
- |
|
Registration of New Companies ( % ) |
<0.1> |
6.2 |
3.0 |
<0.0> |
- |
|
Liquidation of
Companies ( No. ) |
39,075 |
25,585 |
132,476 |
- |
- |
|
Liquidation of Companies ( % ) |
39.6 |
<34.5> |
417.8 |
- |
- |
|
|
|
|
|
|
|
|
Registration of
New Business ( No. ) |
312,581 |
271,414 |
284,598 |
324,761 |
- |
|
Registration of New Business ( % ) |
- |
- |
- |
- |
- |
|
Business
Dissolved ( No. ) |
19,345 |
19,738 |
20,121 |
- |
- |
|
Business Dissolved ( % ) |
2.4 |
2.0 |
1.9 |
- |
- |
|
|
|
|
|
|
|
|
Sales of New Passenger Cars (' 000 Unit ) |
486.3 |
543.6 |
535.1 |
552.2 |
- |
|
Cellular Phone Subscribers ( Million ) |
30.1 |
32.8 |
35.3 |
38.5 |
- |
|
Tourist Arrival ( Million Persons ) |
23.6 |
24.6 |
24.7 |
25.0 |
- |
|
Hotel Occupancy Rate ( % ) |
58.0 |
63.0 |
60.6 |
62.4 |
- |
|
|
|
|
|
|
|
|
Credit Cards Spending ( % ) |
12.8 |
14.1 |
15.6 |
12.6 |
- |
|
Bad Cheque Offenders (No.) |
36,667 |
33,568 |
32,627 |
26,982 |
- |
|
Individual Bankruptcy ( No.) |
16,228 |
18,119 |
19,167 |
19,575 |
- |
|
Individual Bankruptcy ( % ) |
16.7 |
11.7 |
5.8 |
2.1 |
- |
|
|
|
|
|
|
|
|
INDUSTRIES ( %
of Growth ): |
2009 |
2010 |
2011 |
2012* |
2013** |
|
|
|
|
|
|
|
|
Agriculture |
0.4 |
2.1 |
5.9 |
0.6 |
2.4 |
|
Palm Oil |
<1.1> |
<3.4> |
10.8 |
<2.8> |
- |
|
Rubber |
<19.8> |
9.9 |
6.1 |
<0.6> |
- |
|
Forestry & Logging |
<5.9> |
<3.3> |
<7.6> |
<2.2> |
- |
|
Fishing |
5.5 |
5.6 |
2.1 |
<0.7> |
- |
|
Other Agriculture |
9.0 |
7.9 |
7.1 |
6.4 |
- |
|
Industry
Non-Performing Loans ( MYR Million ) |
413.7 |
508.4 |
634.1 |
- |
- |
|
% of Industry
Non-Performing Loans |
1.3 |
2.1 |
3.2 |
- |
- |
|
|
|
|
|
|
|
|
Mining |
<3.8> |
0.2 |
<5.7> |
1.5 |
2.7 |
|
Oil & Gas |
2.1 |
0.5 |
<1.7> |
- |
- |
|
Other Mining |
- |
- |
- |
- |
- |
|
Industry Non-performing
Loans ( MYR Million ) |
44.2 |
49.7 |
46.5 |
- |
- |
|
% of Industry
Non-performing Loans |
0.1 |
0.1 |
0.1 |
- |
- |
|
|
|
|
|
|
|
|
Manufacturing # |
<9.4> |
11.4 |
4.7 |
4.2 |
4.9 |
|
Exported-oriented
Industries |
<19.0> |
12.1 |
2.8 |
4.1 |
- |
|
Electrical & Electronics |
<30.3> |
28.4 |
<4.9> |
1.6 |
- |
|
Rubber Products |
<10.1> |
25.3 |
15.4 |
3.6 |
- |
|
Wood Products |
<24.1> |
20.1 |
<4.9> |
4.6 |
- |
|
Textiles & Apparel |
<19.5> |
<0.4> |
14.8 |
<7.1> |
- |
|
Domestic-oriented
Industries |
<9.8> |
16.3 |
6.5 |
8.6 |
- |
|
Food, Beverages & Tobacco |
0.2 |
3.0 |
4.2 |
- |
- |
|
Chemical & Chemical Products |
<7.7> |
16.2 |
5.5 |
9.9 |
- |
|
Plastic Products |
<9.1> |
2.4 |
3.8 |
- |
- |
|
Iron & Steel |
<32.7> |
29.3 |
2.4 |
- |
- |
|
Fabricated Metal Products |
<2.5> |
14.9 |
25.2 |
- |
- |
|
Non-metallic Mineral |
<15.5> |
20.2 |
27.1 |
6.6 |
- |
|
Transport Equipment |
<13.5> |
36.5 |
<10.4> |
13.7 |
- |
|
Paper & Paper Products |
<5.0> |
18.7 |
14.8 |
<7.8> |
- |
|
Crude Oil Refineries |
0.2 |
<11.4> |
9.3 |
- |
- |
|
Industry
Non-Performing Loans ( MYR Million ) |
6,007.3 |
6,217.5 |
6,537.2 |
- |
- |
|
% of Industry
Non-Performing Loans |
18.3 |
23.8 |
25.7 |
- |
- |
|
|
|
|
|
|
|
|
Construction |
5.8 |
5.1 |
4.4 |
15.5 |
11.2 |
|
Industry Non-Performing Loans ( MYR
Million ) |
3,241.8 |
4,038.5 |
3,856.9 |
- |
- |
|
% of Industry
Non-Performing Loans |
9.9 |
10.7 |
10.2 |
- |
- |
|
|
|
|
|
|
|
|
Services |
2.6 |
6.5 |
6.4 |
5.5 |
5.6 |
|
Electric, Gas & Water |
0.4 |
8.5 |
5.6 |
4.8 |
- |
|
Transport, Storage & Communication |
1.6 |
7.7 |
6.5 |
7.3 |
- |
|
Wholesale, Retail, Hotel & Restaurant |
2.8 |
4.7 |
5.2 |
6.9 |
- |
|
Finance, Insurance & Real Estate |
3.8 |
6.1 |
6.3 |
6.5 |
- |
|
Government Services |
2.0 |
6.7 |
7.6 |
5.6 |
- |
|
Other Services |
4.4 |
4.2 |
5.4 |
5.7 |
- |
|
Industry
Non-Performing Loans ( MYR Million ) |
6,631.3 |
7,384.6 |
6,825.2 |
- |
- |
|
% of Industry
Non-Performing Loans |
20.2 |
25.7 |
23.4 |
- |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* Estimate / Preliminary |
|
|
|
|
|
|
** Forecast |
|
|
|
|
|
|
# Based On Manufacturing Production
Index |
|||||
|
MSIC CODE |
|
|
21001 : Manufacture of medicinal active substances to be used for
their pharmacological properties in the manufacture of medicaments |
|
|
|
|
|
INDUSTRY : |
MANUFACTURING |
|
|
|
|
|
|
|
The Manufacturing sector is one of the important sectors to the growth
of the Malaysian economy. According to Ministry of Finance, the manufacturing
sector is expected to grow 4.9% in year 2013. Export oriented-industries are
expected to benefit from the higher growth of global trade, while
domesticoriented industries expand in line with the better consumer sentiment
and business confidence. The resource-based industries are envisaged to grow
steadily attributed to improved demand for petroleum, chemical, rubber and
plastic products. With better job prospects and higher disposable income, the
transportation equipment subsector, in particular, the passenger car segment
is expected to expand. |
|
|
|
|
|
Value-added of the manufacturing sector expanded 5% during the first
half of 2012. Output of the sector rose 5.2% during the first sevenmonths of
2012 in line with the increase in sales value of manufactured products by
6.5% to RM363.1 billion. Output from domesticoriented industries continued to
expand 8.6% while export-oriented industries grew 4.1%. |
|
|
|
|
|
According to the Department of Statistics, the sales value of the
Manufacturing sector in January 2013 posted a growth of 7.4% (RM3.6 billion) to
record RM52.4 billion as compared to RM48.8 billion reported in year 2012.
Meanwhile, month-on-month basis, the sales value has decreased by 0.4% (RM0.2
billion) as compared with the preceding month. The sales value in December
2012 has been revised positive 7.5% year-on-year to record RM52.6
billion. |
|
|
|
|
|
Output of rubber products increased 3.6% in the first seven month of
2012 mainly supported by continuous demand for rubber gloves. Output of
rubber gloves grew 5.9% on account of the expansion in the global healthcare
industry and wider usage of gloves in other sectors. Similarly, output of
catheters, especially for use in medical appliances, also registered a strong
growth of 12.6%. Nevertheless, production of rubber tyres and tubes reduced
10.9% in tandem with slowing external demand from the automotive industry,
especially China. |
|
|
|
|
|
Meanwhile, production of wood and wood products rebounded 4.6% largely
supported by higher demand for wooden and cane furniture (33.5%). The positive
performance was attributed to vibrant higher demand from major export
destinations such as China and the United States (US) for Malaysian-made
furniture. Demand from China accelerated further following the country’s
rising income level and the implementation of zero import duty on Malaysian
made-furniture. Malaysia government has growth target of 6.5% for wood based
furniture where estimated to reach up to RM53 billion by year 2020.The
government providing pioneer status for tax exemption and investment tax
allowance for this industry as a boost up step towards produce good quality
product and to meet the world demand. |
|
|
|
|
|
The output of chemicals and chemical products rose 9.9% in the first
seven month of year 2012 on account of increasing demand for plastic products
(11.8%) and basic chemicals (11.1%). External demand for plastic packaging
materials surged during the early part of the year 2012, particularly from
Japan and Thailand, as manufacturers resumed operations, which were
interrupted by natural calamities and power outages. Chemical production are
expected to show 7.5 % in year 2013 inline with Malaysia as one of the
largest contributor in world Chemicals & Chemical industries. |
|
|
|
|
|
Tax and non-tax incentives provided by government encourage
manufacturers to move up the value chain of manufacturing industry. The new
growth initiatives by government in the manufacturing sector such assolar and
medial services can be important drivers of growth apart from helping to
diversify the manufacturing base and contributing to the resilience of the
sector. |
|
|
|
|
|
OVERALL INDUSTRY OUTLOOK : Average Growth |
|
|
Incorporated in
1982, the SC is a Private Limited company, focusing on manufacture and
distribution of pharmaceutical products. With experiences for about 32 years
in the industry, the SC's operation has been running relatively stable since
it has built up a relatively sound and stable clientele base which has
contributed to its business growth. Having strong support from its
shareholder has enabled the SC to remain competitive despite the challenging
business environment. The capital standing of the SC is fair. With an
adequate share capital, the SC has the potential of expanding its business in
future. |
|
|
|
THE FINANCIAL
STATEMENTS WERE PREPARED IN ACCORDANCE WITH MALAYSIAN FINANCIAL REPORTING
STANDARDS(FRS) |
|
RANBAXY
(MALAYSIA) SDN. BHD. |
|
Financial Year End |
2011-12-31 |
2010-12-31 |
2009-12-31 |
2008-12-31 |
2007-12-31 |
|
Months |
12 |
12 |
12 |
12 |
12 |
|
Consolidated Account |
Company |
Company |
Company |
Company |
Company |
|
Audited Account |
YES |
YES |
YES |
YES |
YES |
|
Unqualified Auditor's Report (Clean
Opinion) |
YES |
YES |
YES |
YES |
YES |
|
Financial Type |
FULL |
FULL |
FULL |
FULL |
SUMMARY |
|
Currency |
MYR |
MYR |
MYR |
MYR |
MYR |
|
|
|
|
|
|
|
|
TURNOVER |
86,726,000 |
92,728,000 |
109,056,000 |
68,896,000 |
81,809,000 |
|
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
Total Turnover |
86,726,000 |
92,728,000 |
109,056,000 |
68,896,000 |
81,809,000 |
|
Costs of Goods Sold |
<58,185,000> |
<56,765,000> |
- |
- |
- |
|
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
Gross Profit |
28,541,000 |
35,963,000 |
- |
- |
- |
|
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
|
|
|
|
|
|
PROFIT/(LOSS) FROM OPERATIONS |
7,357,000 |
17,087,000 |
16,314,000 |
6,269,000 |
10,610,000 |
|
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
PROFIT/(LOSS) BEFORE TAXATION |
7,357,000 |
17,087,000 |
16,314,000 |
6,269,000 |
10,610,000 |
|
Taxation |
<1,339,000> |
<4,222,000> |
<3,658,000> |
<706,000> |
<2,637,000> |
|
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
PROFIT/(LOSS) AFTER TAXATION |
6,018,000 |
12,865,000 |
12,656,000 |
5,563,000 |
7,973,000 |
|
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
RETAINED
PROFIT/(LOSS) BROUGHT FORWARD |
|
|
|
|
|
|
As previously reported |
61,823,000 |
50,558,000 |
38,862,000 |
34,579,000 |
27,886,000 |
|
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
As restated |
61,823,000 |
50,558,000 |
38,862,000 |
34,579,000 |
27,886,000 |
|
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
PROFIT AVAILABLE FOR APPROPRIATIONS |
67,841,000 |
63,423,000 |
51,518,000 |
40,142,000 |
35,859,000 |
|
DIVIDENDS - Ordinary (paid & proposed) |
<1,360,000> |
<1,600,000> |
<960,000> |
<1,280,000> |
<1,280,000> |
|
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
RETAINED PROFIT/(LOSS) CARRIED FORWARD |
66,481,000 |
61,823,000 |
50,558,000 |
38,862,000 |
34,579,000 |
|
|
============= |
============= |
============= |
============= |
============= |
|
|
|
|
|
|
|
|
INTEREST EXPENSE
(as per notes to P&L) |
|
|
|
|
|
|
Bank overdraft |
767,000 |
567,000 |
1,075,000 |
- |
- |
|
Bankers' acceptance |
- |
68,000 |
- |
- |
- |
|
Revolving loans |
- |
- |
89,000 |
956,000 |
- |
|
Others |
- |
- |
126,000 |
8,000 |
- |
|
|
---------------- |
---------------- |
---------------- |
---------------- |
|
|
|
767,000 |
635,000 |
1,290,000 |
964,000 |
|
|
RANBAXY
(MALAYSIA) SDN. BHD. |
|
ASSETS EMPLOYED: |
|
|
|
|
|
|
FIXED ASSETS |
25,093,000 |
23,037,000 |
23,001,000 |
24,219,000 |
19,509,000 |
|
|
|
|
|
|
|
|
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
TOTAL LONG TERM ASSETS |
25,093,000 |
23,037,000 |
23,001,000 |
24,219,000 |
19,509,000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS |
|
|
|
|
|
|
Stocks |
30,950,000 |
24,062,000 |
27,857,000 |
20,176,000 |
- |
|
Trade debtors |
47,492,000 |
41,107,000 |
40,364,000 |
24,650,000 |
- |
|
Other debtors, deposits & prepayments |
4,003,000 |
3,024,000 |
2,256,000 |
2,538,000 |
- |
|
Amount due from holding company |
2,921,000 |
2,844,000 |
1,908,000 |
- |
- |
|
Cash & bank balances |
466,000 |
341,000 |
1,443,000 |
1,342,000 |
- |
|
Others |
281,000 |
111,000 |
- |
1,089,000 |
- |
|
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
TOTAL CURRENT ASSETS |
86,113,000 |
71,489,000 |
73,828,000 |
49,795,000 |
65,994,000 |
|
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
TOTAL ASSET |
111,206,000 |
94,526,000 |
96,829,000 |
74,014,000 |
85,503,000 |
|
|
============= |
============= |
============= |
============= |
============= |
|
|
|
|
|
|
|
|
CURRENT
LIABILITIES |
|
|
|
|
|
|
Trade creditors |
5,630,000 |
3,650,000 |
6,063,000 |
1,788,000 |
- |
|
Other creditors & accruals |
4,624,000 |
2,338,000 |
7,304,000 |
3,490,000 |
- |
|
Bank overdraft |
11,568,000 |
12,162,000 |
- |
- |
- |
|
Other borrowings |
- |
- |
- |
16,900,000 |
- |
|
Bill & acceptances payable |
- |
1,735,000 |
2,301,000 |
1,778,000 |
- |
|
Amounts owing to holding company |
13,396,000 |
2,483,000 |
10,686,000 |
1,246,000 |
- |
|
Amounts owing to related companies |
- |
- |
8,993,000 |
- |
- |
|
Provision for taxation |
- |
- |
1,857,000 |
- |
- |
|
Other liabilities |
75,000 |
693,000 |
640,000 |
- |
- |
|
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
TOTAL CURRENT LIABILITIES |
35,293,000 |
23,061,000 |
37,844,000 |
25,202,000 |
41,124,000 |
|
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
NET CURRENT ASSETS/(LIABILITIES) |
50,820,000 |
48,428,000 |
35,984,000 |
24,593,000 |
24,870,000 |
|
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
TOTAL NET ASSETS |
75,913,000 |
71,465,000 |
58,985,000 |
48,812,000 |
44,379,000 |
|
|
============= |
============= |
============= |
============= |
============= |
|
|
|
|
|
|
|
|
SHARE CAPITAL |
|
|
|
|
|
|
Ordinary share capital |
8,000,000 |
8,000,000 |
8,000,000 |
8,000,000 |
8,000,000 |
|
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
TOTAL SHARE CAPITAL |
8,000,000 |
8,000,000 |
8,000,000 |
8,000,000 |
8,000,000 |
|
|
|
|
|
|
|
|
RESERVES |
|
|
|
|
|
|
Share premium |
300,000 |
300,000 |
300,000 |
300,000 |
300,000 |
|
Retained profit/(loss) carried forward |
66,481,000 |
61,823,000 |
50,558,000 |
38,862,000 |
34,579,000 |
|
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
TOTAL RESERVES |
66,781,000 |
62,123,000 |
50,858,000 |
39,162,000 |
34,879,000 |
|
|
|
|
|
|
|
|
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
SHAREHOLDERS' FUNDS/EQUITY |
74,781,000 |
70,123,000 |
58,858,000 |
47,162,000 |
42,879,000 |
|
|
|
|
|
|
|
|
LONG TERM
LIABILITIES |
|
|
|
|
|
|
Deferred taxation |
1,132,000 |
1,342,000 |
127,000 |
1,650,000 |
- |
|
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
TOTAL LONG TERM LIABILITIES |
1,132,000 |
1,342,000 |
127,000 |
1,650,000 |
1,500,000 |
|
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
75,913,000 |
71,465,000 |
58,985,000 |
48,812,000 |
44,379,000 |
|
|
============= |
============= |
============= |
============= |
============= |
|
RANBAXY
(MALAYSIA) SDN. BHD. |
|
TYPES OF FUNDS |
|
|
|
|
|
|
Cash |
466,000 |
341,000 |
1,443,000 |
1,342,000 |
- |
|
Net Liquid Funds |
<11,102,000> |
<13,556,000> |
<858,000> |
<436,000> |
- |
|
Net Liquid Assets |
19,870,000 |
24,366,000 |
8,127,000 |
4,417,000 |
24,870,000 |
|
Net Current Assets/(Liabilities) |
50,820,000 |
48,428,000 |
35,984,000 |
24,593,000 |
24,870,000 |
|
Net Tangible Assets |
75,913,000 |
71,465,000 |
58,985,000 |
48,812,000 |
44,379,000 |
|
Net Monetary Assets |
18,738,000 |
23,024,000 |
8,000,000 |
2,767,000 |
23,370,000 |
|
BALANCE SHEET
ITEMS |
|
|
|
|
|
|
Total Borrowings |
11,568,000 |
13,897,000 |
2,390,000 |
19,634,000 |
- |
|
Total Liabilities |
36,425,000 |
24,403,000 |
37,971,000 |
26,852,000 |
42,624,000 |
|
Total Assets |
111,206,000 |
94,526,000 |
96,829,000 |
74,014,000 |
85,503,000 |
|
Net Assets |
75,913,000 |
71,465,000 |
58,985,000 |
48,812,000 |
44,379,000 |
|
Net Assets Backing |
74,781,000 |
70,123,000 |
58,858,000 |
47,162,000 |
42,879,000 |
|
Shareholders' Funds |
74,781,000 |
70,123,000 |
58,858,000 |
47,162,000 |
42,879,000 |
|
Total Share Capital |
8,000,000 |
8,000,000 |
8,000,000 |
8,000,000 |
8,000,000 |
|
Total Reserves |
66,781,000 |
62,123,000 |
50,858,000 |
39,162,000 |
34,879,000 |
|
LIQUIDITY
(Times) |
|
|
|
|
|
|
Cash Ratio |
0.01 |
0.01 |
0.04 |
0.05 |
- |
|
Liquid Ratio |
1.56 |
2.06 |
1.21 |
1.18 |
- |
|
Current Ratio |
2.44 |
3.10 |
1.95 |
1.98 |
1.60 |
|
WORKING CAPITAL
CONTROL (Days) |
|
|
|
|
|
|
Stock Ratio |
130 |
95 |
93 |
107 |
- |
|
Debtors Ratio |
200 |
162 |
135 |
131 |
- |
|
Creditors Ratio |
35 |
23 |
20 |
9 |
- |
|
SOLVENCY RATIOS
(Times) |
|
|
|
|
|
|
Gearing Ratio |
0.15 |
0.20 |
0.04 |
0.42 |
- |
|
Liabilities Ratio |
0.49 |
0.35 |
0.65 |
0.57 |
0.99 |
|
Times Interest Earned Ratio |
10.59 |
27.91 |
13.65 |
7.50 |
- |
|
Assets Backing Ratio |
9.49 |
8.93 |
7.37 |
6.10 |
5.55 |
|
PERFORMANCE
RATIO (%) |
|
|
|
|
|
|
Operating Profit Margin |
8.48 |
18.43 |
14.96 |
9.10 |
12.97 |
|
Net Profit Margin |
6.94 |
13.87 |
11.61 |
8.07 |
9.75 |
|
Return On Net Assets |
10.70 |
24.80 |
29.84 |
14.82 |
23.91 |
|
Return On Capital Employed |
9.29 |
21.19 |
29.80 |
14.53 |
23.91 |
|
Return On Shareholders' Funds/Equity |
8.05 |
18.35 |
21.50 |
11.80 |
18.59 |
|
Dividend Pay Out Ratio (Times) |
0.23 |
0.12 |
0.08 |
0.23 |
0.16 |
|
NOTES TO
ACCOUNTS |
|
|
|
|
|
|
Contingent Liabilities |
0 |
0 |
0 |
0 |
|
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.61.69 |
|
UK Pound |
1 |
Rs.98.59 |
|
Euro |
1 |
Rs.83.67 |
INFORMATION DETAILS
|
Report
Prepared by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.